|
⚲
|
| Keyboard |
| O'Brien Stephanie Monaghan
✚
|
|
|---|---|
| CIK # | 0001720907 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001720907] | |
| 4 | [0001720907] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Apellis Pharmaceuticals Inc | |
| O'Brien Stephanie Monaghan |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2026-01-01 | Grant | 7,961 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2026-01-01 | Grant | 14,684 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2025-01-01 | Grant | 6,267 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2025-01-01 | Grant | 11,199 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2024-01-01 | Grant | 3,341 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2024-01-01 | Grant | 5,748 | $59.86 | 344,075 |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2023-01-01 | Grant | 7,441 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2023-01-01 | Grant | 3,867 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2022-01-01 | Grant | 8,554 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Common Stock
|
2022-01-01 | Grant | 4,230 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2021-01-01 | Grant | 27,600 | $0.00 | |
|
Apellis Pharmaceuticals Inc APLS
Stock Option (Right to Buy) · derivative
|
2020-01-01 | Grant | 27,600 | $30.62 | 845,112 |
|
Apellis Pharmaceuticals Inc APLS
Stock option (right to buy) · derivative
|
2019-01-01 | Grant | 17,580 | $0.00 |